Drug intelligence / Profile preview

West Nile virus vaccine (Phylex BioSciences)

Development stage: Preclinical
Lead developer: Phylex BioSciences
Modality: mRNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Nanoparticles → Drug Delivery Systems, Vaccines & Immunotherapeutics
Administration: Intramuscular

Overview

Phylex BioSciences' West Nile virus vaccine is a preclinical mRNA-based candidate designed to prevent West Nile virus infection. The vaccine utilizes a proprietary platform where messenger RNA encodes a viral antigen that self-assembles into a nanoparticle structure. This technology is intended to mimic the structure of a virus-like particle (VLP), displaying multiple copies of the antigen to the immune system to elicit a robust and durable immune response. The platform aims to combine the rapid development advantages of mRNA with the high immunogenicity of nanoparticle-based antigen presentation.

Other names: Phylex West Nile virus vaccinePhylex mRNA West Nile vaccine

Beyond the preview

Go deeper on West Nile virus vaccine (Phylex BioSciences).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on West Nile virus vaccine (Phylex BioSciences).

Explore the full profile